Regenxbio Inc (RGNX)

08:08 AM

Leerink Partners raises Regenxbio stock price target to $20 on DMD opportunity - Investing.com UK

08:08 AM

Dec 14, 2025

RegenXBio’s Gene Therapy Study for Hunter Syndrome: A Potential Game-Changer - TipRanks

Dec 14, 2025

Dec 13, 2025

REGENXBIO (NASDAQ:RGNX) Stock Price Up 5.2%Time to Buy? - MarketBeat

Dec 13, 2025

Dec 11, 2025

(RGNX) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Dec 11, 2025

Dec 08, 2025

REGENXBIO (NASDAQ:RGNX) Reaches New 52-Week HighShould You Buy? - MarketBeat

Dec 08, 2025

Dec 08, 2025

Wet Age-Related Macular Degeneration Market Growth - openPR.com

Dec 08, 2025

Dec 08, 2025

Voss Capital LP Boosts Stock Holdings in REGENXBIO Inc. $RGNX - MarketBeat

Dec 08, 2025

Dec 08, 2025

REGENXBIO Inc. $RGNX is 22NW LP's 5th Largest Position - MarketBeat

Dec 08, 2025

Dec 05, 2025

Will REGENXBIO Inc. (RB0) stock announce special dividend2025 Major Catalysts & Real-Time Volume Spike Alerts - Newser

Dec 05, 2025

Dec 05, 2025

What insider trading reveals about REGENXBIO Inc. stockJuly 2025 Snapshot & Smart Allocation Stock Tips - Newser

Dec 05, 2025

Dec 05, 2025

Why global investors buy REGENXBIO Inc. (RB0) stock2025 Market WrapUp & Safe Capital Allocation Plans - Newser

Dec 05, 2025

Dec 04, 2025

Will REGENXBIO Inc. (RB0) stock profit from fiscal stimulus2025 Big Picture & Safe Entry Zone Identification - Newser

Dec 04, 2025

Dec 04, 2025

Can REGENXBIO Inc. stock resist market sell offsQuarterly Profit Review & Technical Pattern Based Signals - Newser

Dec 04, 2025

Dec 04, 2025

Is REGENXBIO Inc. stock resilient to inflationGold Moves & Fast Exit Strategy with Risk Control - Newser

Dec 04, 2025

Dec 03, 2025

JPMorgan Chase & Co. Sells 512,318 Shares of REGENXBIO Inc. $RGNX - MarketBeat

Dec 03, 2025

Dec 02, 2025

Will REGENXBIO Inc. (RB0) stock see valuation expansionWeekly Trade Analysis & Reliable Trade Execution Plans - Newser

Dec 02, 2025

Dec 01, 2025

REGENXBIO announces royalty monetization agreement for up to $250M - MSN

Dec 01, 2025

Dec 01, 2025

Commercial Lessons From The Cell And Gene Therapy Frontlines - Citeline News & Insights

Dec 01, 2025

Nov 30, 2025

How (RGNX) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

Nov 30, 2025

Nov 30, 2025

26,773 Shares in REGENXBIO Inc. $RGNX Bought by Rockefeller Capital Management L.P. - MarketBeat

Nov 30, 2025

Nov 28, 2025

REGENXBIO Inc. (NASDAQ:RGNX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 28, 2025

Nov 27, 2025

Gainers Report: Is REGENXBIO Inc. stock a contrarian buyJuly 2025 Summary & Risk Managed Trade Strategies - moha.gov.vn

Nov 27, 2025

Nov 27, 2025

REGENXBIO (RGNX) Q3 2025 Earnings Call Transcript - The Globe and Mail

Nov 27, 2025

Nov 27, 2025

Regenxbio files $300M mixed securities shelf - MSN

Nov 27, 2025

Nov 27, 2025

Transcript : REGENXBIO Inc. Presents at Stifel 2025 Healthcare Conference, Nov-11-2025 01 - marketscreener.com

Nov 27, 2025

Nov 26, 2025

Regenxbio files $300M mixed shelf offering - MSN

Nov 26, 2025

Nov 26, 2025

Regenxbio (RGNX) Files for $300M Securities Offering - GuruFocus

Nov 26, 2025

Nov 26, 2025

Regenxbio files for mixed shelf of up to $300 millionSEC filing - marketscreener.com

Nov 26, 2025

Nov 26, 2025

[S-3] REGENXBIO Inc. Shelf Registration Statement | RGNX SEC FilingForm S-3 - Stock Titan

Nov 26, 2025

Nov 25, 2025

Does REGENXBIO (NASDAQ:RGNX) Have A Healthy Balance Sheet? - 富途牛牛

Nov 25, 2025

Nov 25, 2025

REGENXBIO to Participate in Upcoming Investor Conference - PR Newswire

Nov 25, 2025

Nov 25, 2025

REGENXBIO (Nasdaq: RGNX) Fireside Chat at Piper Sandler 37th Healthcare Conference - Stock Titan

Nov 25, 2025

Nov 25, 2025

Regenxbio up 4% following additional data on Duchenne gene therapy asset - MSN

Nov 25, 2025

Nov 24, 2025

Brokers Set Expectations for REGENXBIO FY2026 Earnings - MarketBeat

Nov 24, 2025

Nov 21, 2025

REGENXBIO (NASDAQ:RGNX) Given Buy Rating at Chardan Capital - MarketBeat

Nov 21, 2025

Nov 20, 2025

RGNX S-8及美國證券交易委員會申報文件 - Yahoo 財經

Nov 20, 2025

Nov 20, 2025

Chardan Capital Maintains Buy Rating for RGNX with $52 Price Tar - GuruFocus

Nov 20, 2025

Nov 20, 2025

Is REGENXBIO Inc. (RB0) stock safe for risk averse investors2025 Earnings Impact & Precise Swing Trade Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Will REGENXBIO Inc. (RB0) stock profit from AI boomJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

How REGENXBIO Inc. stock responds to policy changes2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Visualizing REGENXBIO Inc. stock with heatmapsWeekly Trade Recap & Intraday High Probability Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Reversal indicators forming on REGENXBIO Inc. stock2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Trading Systems Reacting to (RGNX) Volatility - news.stocktradersdaily.com

Nov 19, 2025

Nov 19, 2025

Will REGENXBIO Inc. stock split again soonTrade Ideas & Precise Buy Zone Tips - newser.com

Nov 19, 2025

Nov 19, 2025

What data driven models say about REGENXBIO Inc.’s futurePortfolio Value Summary & Consistent Income Trade Recommendations - newser.com

Nov 19, 2025